Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TuNEX (ENIA11) in Combination with DMARDs for Rheumatoid Arthritis
NCT01787149Phase 3Unknown
- Sponsor
- Mycenax Biotech Inc.
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Mycenax Biotech Inc.. Status: unknown.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01787149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787149.